Eric Martinez, MD, a fellowship-trained, multi-organ abdominal transplant surgeon, has been named surgical director of kidney and pancreas transplant at Baylor University Medical Center (Baylor Dallas), part of Baylor Scott & White Health. He is fluent in both English and Spanish.
Dr. Martinez joined the transplant team at Baylor Dallas in 2018. He is also on the medical staff at Baylor Scott & White All Saints Medical Center – Fort Worth. Dr. Martinez performs liver, kidney and pancreas transplants, taking care of patients with end-stage organ disease throughout all phases of their care. He also takes care of living kidney donors.
“Transplant surgery is a complex medical and surgical field where there is constant learning, evolving and growing,” Dr. Martinez says. “Transplant surgery is a rewarding field because of the positive impact that it makes on patients’ lives, often very quickly and drastically.
“Patient education and setting expectations are the cornerstones of establishing a healthy patient/physician relationship, and our transplant team seeks to accomplish that with every interaction. We’re committed to seeing the patient past end-stage organ disease to their return to a normal, healthy life,” he continues.
Dr. Martinez earned his medical degree at Florida State University and went on to complete a general surgery residency at the University of Texas Health Science Center in Houston. He then completed a fellowship in multi-organ abdominal transplantation at the University of Wisconsin in Madison.
Dr. Martinez is an adjunct assistant professor at Texas A&M Health Science Center and teaches residents and fellows at Baylor Dallas. His research interests include outcomes of dual organ transplants.
Size image above at 800x600. Add call to action here, copy from the sidebar (if available) or from the bottom of the page.
Baylor Scott & White takes lead on improving liver health
The burden of liver disease is increasing in Dallas/Fort Worth and throughout the nation. In addition to alcohol abuse or misuse, there has been an alarming increase in the incidence of non-alcoholic fatty liver disease, a leading cause of cirrhosis.
Baylor Scott & White transplant team performs its 21st robotic living donor hepatectomy
Living liver donors report an immense emotional and spiritual benefit from knowing they are saving the life of a loved one. However, it is impossible to overlook the surgical trauma, cosmetic scars and surgical risks to which otherwise healthy donors are exposed with this major operation. To mitigate the potential harm to donors, Baylor Scott & White Annette C. and Harold C. Simmons Transplant Institute has begun performing robotic living donor hepatectomies, one of only two programs in the United States to do so.
New preservation technologies transform liver transplant
Three new organ preservation systems allow transplant surgeons to travel farther distances to procure donor livers and provide the ability to better assess potential donor livers that may have borderline function. Through the use of these new preservation systems, Baylor Scott & White Annette C. and Harold C. Simmons Transplant Institute has greatly expanded its options for accepting donor livers.
Baylor Scott & White Health delivers multidisciplinary care to combat rise in liver cancer
In Texas, a disproportionate number of people have non-alcoholic fatty liver disease, non-alcoholic steatohepatitis (NASH) and NASH cirrhosis. Combine these conditions with alcohol misuse, and you have a state with the highest rate of liver cancer in the nation.